Independent risk factors for lymph node metastasis in 2623 patients with Non-Small cell lung cancer

被引:8
|
作者
Xue, Xinying [1 ]
Zang, Xuelei [2 ]
Liu, Yuxia [3 ]
Lin, Dongliang [4 ]
Jiang, Tianjiao [5 ]
Gao, Jie [6 ]
Wu, Chongchong [7 ]
Ma, Xidong [8 ]
Deng, Hui [1 ]
Yu, Zhaofeng [9 ]
Pan, Lei [1 ]
Xue, Zhiqiang [10 ]
机构
[1] Capital Med Univ, Beijing Shijitan Hosp, Dept Resp & Crit Care, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Ctr Clin Lab Med, Beijing, Peoples R China
[3] Peking Union Med Coll Hosp, Dept Sci Res, Beijing, Peoples R China
[4] Qingdao Univ, Dept Pathol, Affiliated Hosp, Qingdao, Peoples R China
[5] Qingdao Univ, Dept Radiol, Affiliated Hosp, Qingdao, Peoples R China
[6] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Pathol, Beijing, Peoples R China
[7] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Radiol, Beijing, Peoples R China
[8] Weifang Med Univ, Dept Resp Med, Weifang, Peoples R China
[9] Weifang Med Univ, Weifang, Peoples R China
[10] Chinese Peoples Liberat Army Gen Hosp, Med Ctr 1, Dept Thorac Surg, Beijing, Peoples R China
来源
SURGICAL ONCOLOGY-OXFORD | 2020年 / 34卷
关键词
Non-small cell lung cancer; Lymph node metastasis; Ki-67; Risk factors; 8TH EDITION; RESECTION; SURVIVAL; MARKERS;
D O I
10.1016/j.suronc.2020.05.005
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: this study attempts to identify the independent risk factors that can predict lymph node metastasis for the patients with non-small cell lung cancer (NSCLC), and guide doctor adoption of individualized treatment for such patients. Materials and methods: This study was approved by the Hospital's Ethics Committee and all patients had signed informed consent forms. We retrospectively reviewed NSCLC patients who had undergone surgical resection from December 2008 to December 2013. The statistical significance of evaluation variables and lymph node metastasis was determined with Pearson's Chi-square test. The risk factors of lymph node metastasis were determined through univariate and multivariate logistic regression analysis. And for the age and tumor diameter factors, optimal cutoff points were determined with a receiver operating characteristic analysis. Results: In the present study, a total of 2623 patients were included in the study, and 779 patients with lymph node metastasis. Three independent risk factors were identified: age, tumor diameter and Ki-67 index. We found that <65 years of age (Adjusted-OR:1.921), >=.2.85 cm of tumor diameter (Adjusted-OR:3.141), and 5% similar to 25% in Ki-67 group (Adjusted-OR:2.137), >= 25% (Adjusted-OR:3.341) were significant. Also we found that 307 patients with lymph node metastasis and the lymph node metastasis rate was 51.0%, when the age<65 years, Ki-67 index >= 25%, and the tumor diameter >= 2.85 cm. On the contrary, there were only 2 patients with lymph node metastasis, and the rate of lymph node metastasis was 5.1%. Conclusion: Identifying three independent risk factors that predict lymph node metastasis in non-small cell patients, Among NSCLC patients in whom all three predictors were identified, and over a half of the patients showed lymph node metastasis.
引用
收藏
页码:256 / 260
页数:5
相关论文
共 50 条
  • [41] Mediastinal lymph node dissection in older patients with non-small cell lung cancer
    Tomohiro Maniwa
    Toru Kimura
    Masayuki Ohue
    Jiro Okami
    [J]. Surgery Today, 2022, 52 : 458 - 464
  • [42] Impact of lymph node management on resectable non-small cell lung cancer patients
    Tantraworasin, Apichat
    Saeteng, Somcharoen
    Siwachat, Sophon
    Jiarawasupornchai, Tawatchai
    Lertprasertsuke, Nirush
    Kongkarnka, Sarawut
    Ruengorn, Chidchanok
    Patumanond, Jayanton
    Taioli, Emanuela
    Flores, Raja M.
    [J]. JOURNAL OF THORACIC DISEASE, 2017, 9 (03) : 666 - 674
  • [43] Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis
    Kitano, Haruhisa
    Chung, Joon-Yong
    Noh, Kyung Hee
    Lee, Young-Ho
    Kim, Tae Woo
    Lee, Seok Hyung
    Eo, Soo-Heang
    Cho, Hyung Jun
    Choi, Chel Hun
    Inoue, Shuhei
    Hanaoka, Jun
    Fukuoka, Junya
    Hewitt, Stephen M.
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2017, 15
  • [44] Lymphatic Vessel Invasion and Lymph Node Metastasis in Patients with Clinical Stage I Non-Small Cell Lung Cancer
    Kang, Du-Young
    Lee, Sungsoo
    [J]. THORACIC AND CARDIOVASCULAR SURGEON, 2014, 62 (06): : 521 - 524
  • [45] Usefulness of the neutrophil-to-lymphocyte ratio in predicting lymph node metastasis in patients with non-small cell lung cancer
    Huang, Chongbiao
    Yue, Jie
    Li, Zengxun
    Li, Na
    Zhao, Jinkun
    Qi, Daliang
    [J]. TUMOR BIOLOGY, 2015, 36 (10) : 7581 - 7589
  • [46] RADIOTHERAPY FOR POSTOPERATIVE THORACIC LYMPH NODE RECURRENCE IN PATIENTS WITH NON-SMALL CELL LUNG CANCER WITHOUT DISTANT METASTASIS
    Okami, Jiro
    Nishiyama, Kinji
    Fujiwara, Ayako
    Konishi, Koji
    Kanou, Takashi
    Tokunaga, Toshiteru
    Teshima, Teruki
    [J]. JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S1132 - S1133
  • [47] Synaptonemal complex protein 3 is associated with lymphangiogenesis in non-small cell lung cancer patients with lymph node metastasis
    Haruhisa Kitano
    Joon-Yong Chung
    Kyung Hee Noh
    Young-Ho Lee
    Tae Woo Kim
    Seok Hyung Lee
    Soo-Heang Eo
    Hyung Jun Cho
    Chel Hun Choi
    Shuhei Inoue
    Jun Hanaoka
    Junya Fukuoka
    Stephen M. Hewitt
    [J]. Journal of Translational Medicine, 15
  • [48] Mediastinal lymph node dissection for non-small cell lung cancer
    Allen, MS
    [J]. JOURNAL OF THORACIC AND CARDIOVASCULAR SURGERY, 2005, 130 (02): : 241 - 242
  • [49] Downregulation of RECK by promoter methylation correlates with lymph node metastasis in non-small cell lung cancer
    Chang, Huang-Chou
    Cho, Chun-Yu
    Hung, Wen-Chun
    [J]. CANCER SCIENCE, 2007, 98 (02): : 169 - 173
  • [50] Intrapulmonary lymph node (stations 13 and 14) metastasis in peripheral non-small cell lung cancer
    Bi, Lei
    Zhang, Hong
    Ge, Mingjian
    Lv, Zhongzhu
    Deng, Yiping
    Rong, Tenghao
    Liu, Chaolun
    [J]. MEDICINE, 2021, 100 (27)